UnicoCell

Home > News > Press Release

- Press Release
- Events

Press Release

2024-04-18 2024.04.18 UnicoCell Biomed held a Pre-IPO Investor Conference on the TIB (Taiwan Innovation Board)
2024-02-17 2024.02.17 The stem cell new drug, ELIXCYTE, honored by the international journal Cytotherapy acceptance
2023-11-28 2023.11.28 UnicoCell, Taiwan Leading Company of Promising Allogeneic Stem Cell New Drug, applied to Taiwan Stock Exchange for IPO on Innovative Board
2023-11-09 2023.11.09 The Ministry of Health and Welfare approved the application for the RASMET in cooperation with the PaoChien Hospital.
2023-08-15 2023.8.15 UnicoCell received Acknowledgment letter of MF (Master File) from US FDA for UnicoCell Conditioned Medium (UCCM)
2023-07-10 2023.7.10 Unicocell Biomed Enrolls First Participant in Phase III Clinical Trial for Knee Osteoarthritis
2023-03-31 2023.3.31 Unicocell Biomed Joins Taiwan Extracellular Vesicle Industry-Academia Association as a Member of the STEERING COMMITTEE
2023-03-03 2023.3.3 Unicocell Biomed Knee Osteoarthritis Treatment Receives FDA approval for Phase III Clinical Trial
2023-02-14 2023.2.14 Unicocell Biomed New Drug Receives Certification from SNQ
2023-02-08 2023.2.8 Approval Granted for Unicocell Biomed to Initiate Phase III Clinical Trial for Knee Osteoarthritis Treatment

«
1
2
3
4
5
»

2 page / total 5